Single Dose Zoledronic Acid Effective for Paget’s Prevention

Jonathan Tang

Press/Media: Media Coverage or Contribution

Description

Coverage from the Society for Endocrinology (SfE) BES 2023

13-15 Nov 2023, Glasgow, Scotland

Period	14 Nov 2023

Media coverage

1

Media coverage

Title Medscape UK
Degree of recognition International
Media name/outlet Medscape UK
Media type Web
Country/Territory United Kingdom
Date 14/11/23
Producer/Author Becky McCall
Persons Jonathan Tang

Related content

Research output
A single infusion of Zoledronic acid suppressed bone turnover markers for up to seven years: Results from the Zoledronate in the Prevention of Paget's disease (ZiPP) study
Research output: Contribution to conference › Paper › peer-review